메인페이지 Conference Invited Speakers' Page

Invited Speakers' Page
Track1.Regulatory Innovation_Biosimilar/Standardization in Bioindustry
 
Anne  Kranich
Chief Regulatory Officer, Prestige BioPharma
 
Dianne Jackson-Matthews
Deputy Group Director,
ERA Consulting(Australia) Pty Ltd
 
Per Troein
VP Strategic Partners,
IMS Health,
 
Dongho  Lee
Professor, University of Ulsan College of Medicine
 
 
Seok Goo  CHANG
CEO, Flesin Korea Co., Ltd.
 
Paul H SONG
Director, Vice President, Samsung Bioepis
Duk Jae Oh
Professor, Sejong University
 
Jongwon Kim
Director, LabGenomics Co., Ltd.
Tatsuo Heki
Senior Expert, Healthcare Business Development Office, Fujifilm Corporation, Japan
 
Jaeseung Lim
Executive Director, R&D Team, Cha Biotech
   
 
Track 2. Technology Innovation_Genome Editing
 
Seung Shin  Yu
Director, Viromed
 
 
Hyongbum  Kim
Associate Professor, Yonsei University College of Medicine
 
Sangsu  Bae
Assistant Professor, Hanyang University
 
Jeong Hun Kim
Associate Professor, Seoul National University College of Medicine
 
 
Dong-Wook Kim
Professor, Yonsei University College of Medicine
 
Jin-Soo Kim
Center for Genome Engineering, IBS
 
Muthiah (Mano) Manoharan
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals
 
Dong-ki Lee
Professor,
Sungkyunkwan University
 
Keiji Nishida
Professor, Graduate School of Science, Technology and Innovation, Kobe University
 
Track3. Capital Innovation_VC Accelerator(HI KOREA Invest Fair 2017)
 
Jungseob Shin
Director, KB Investment
 
 
Jong Hyun Lee
Deputy General Manager, Synergy IB Investment
 
Myung Kee Kim
CEO, LSK Investment
 
OH SUNG SOO
MANAGING DIRECTOR, SOLIDUS INVESTMENT CO., LTD.
 
 
Harry OH
CEO, Brightstar Partners
 
Chris Winter
Founder/ Managing Partner, Brightstar Partners Ltd., UK
 
Claire Williams
President and CEO, Dragon Consulting Group, USA
 
 
Patrick O'Neill
Partner, Calice Group LLC
 
Andy  Jang
CEO, Stassets Investment
 
David Flores
President&CEO, BioCentury
   
 
Track 4. Virtual Biopharma
 
James Jungkue Lee
CEO, Bridge Biotherapeutics, Inc
 
 
Chang-Sun Lee
CTO, RaND Bio
 
Michael Schaeffer
Managing Director, CRELUX-a WuXiAppTec company
 
Jong Sung Koh
CTO, GENOSCO
 
 
Kiyeon Nam
CEO, Qurient
 
Sukkyoon Yoon
President, New Drug Development Center at DGMIF
 
Christopher Kim
Managing Partner, Novatio Ventures
 
   
 
Track 5. Intellectual Property
 
Eunkyeong Lee
Managing Partner, BKL
 
 
손미경
Senior Researcher, Business Planning Team, Korea Institute of Patent Information
 
Gary J. Speier
Partner, Caspers Vandenburgh Lindquist & Schuman, PA
 
Sam Lockner
Partner, Caspers Vandenburgh Lindquist & Schuman, PA
 
Robert Andrews
Partner, MEWBURN ELLIS LLP
 
Taecksoo Kwon
Partner, IP Group, BKL(Bae,Kim & Lee LLC)
 
Dookyu Kim
Director General, LES Korea
 
 
Jeateck Ryu
Senior Researcher, IP Analysis Team, PIPC(Patent Information Promotion Center)
 
Kisuk Lee
Partner, Harness Dickey and Pierce Law Firm
 
Frédérique Faivre Petit
Partner, Regimbeau
 
Marc Levieils
Partner, Regimbeau
 
Ingu Jung
Patent Attorney, Electronics Team, Wooin Patent & Law Firm
 
Track 6. Technology Licensing
 
Sheila Babnis
Founder, Insights & Impact, Columbia University Health IT Lab Advisor
 
Sebastian Fernandez
Managing Director, Fernandez Health Care Consultants
 
Min Soo Park
Director, Division of Medical Science Research Affairs, Yonsei University Health System
 
Kwang Ho CHEONG
CEO, ImmuneOncia Therapeutics
 
Austin Kozman
R&D Director, Open Innovation & Alliance Management, PEPSICO
 
Ann Damien
New Technology Associate, Cook Medical
 
Christian J. Suojanen
Co-Founder & Chairman, TTS Global Initiative
 
Jiwon Go
Managing Director, VisionMed Australia
 
Roh Charlie
CEO, International Development Dept., PharmaPhenix
 
Michael Chen
Head of External Innovation, Merck R&D Beijing Hub, MERCK
 
Changjae Woo
Chief, Office of Technology, National Cancer Center
 
 
 
Track 7. Digital Healthcare
 
Young-Hak Kim
Director, Health Innovation Big Data Center, ASAN Medical Center
 
David Hansen
CEO, Australian e-Health Research Centre, CSIRO
 
Rong-Min Baek
Chief Research Officer/Senior Vice President, Seoul National University Bundang Hospital
 
Jin Ok Jeon
CEO , BITcomputer Co. LTD
 
Dong Kyung Chang
Director, Digital Healthcare Research Center, Samsung Medical Center
 
Mikko Kauppinen
Village Chief, GE Health Innovation Village
 
Sang Eun Lee
Professor, Department of Health - IT Accleration Platform, Yonsei University Health System
 
Wonsoo Yun
CEO, T&R Biofab
 
James K. Kim
CEO, SELVAS AI
 
Jinhwan Lim
Division Director, Healthcare Business Division, AIMMED
   
 
Track 8. Global Innovative Biotherapeutics & Regenerative Medicine
 
Keiya Ozawa
Professor, Division of Genetic Therapeutics, IMSUT Hospital, The University of Tokyo Center for Gene & Cell Therapy (CGCT)
 
Glenn Cross
CEO, AusBiotech
 
Ross Macdonald
CEO, Cynata Therapeutics
 
Duncan Thomson
Head, Regeneus
 
Takuya Yokokawa
Head, Steering Committee, FIRM(Forum for Innovative Regenerative Medicine)
 
Tae Gyu Lee
President, New Drug Development Center, Osong Medical Innovation Foundation
 
Sunuk Song
CEO, Office of President, SCM LIFE SCIENCE
 
Meehyun Jung
Director, Product Development & RA MEDIPOST Co., Ltd.
 
Jae-Gyun Jeong
Ph.d. Director, R&D Department, ViroMed Co.,Ltd.
 
Youngbin Hong
Director, R&D Center, ToolGen.Inc
 
Ji Won Sarah Choi
Chief of Laboratory/Director, Research and Development Center, Sillajen Co. Inc
 
Jin Won Youn
Director, Clinical Planning, Genexine Inc.
 
Yu-Kyeong Hwang
Green Cross Labcell
 
Bumsup Lee
Executive Vice President, Bio Business Division, KOLON LIFE SCIENCE, INC.
 
Silvio Tiziani
Chair, AusBiotech Regenerative Medicine Advisory Group
 
Seigo Izumo
Senior Vice President, Global Head of Regenerative Medicine Unit, Head of Scientific Affairs Japan, Takeda Pharmaceutical Company Limited
 
Katsuhiko Tachibana
Scientific advisory fellow, JCR Pharmaceuticals Co., Ltd.
 
 
 
T9. New South Korea-Canada (Ontario) Global Commercialization Initiative
 
Raphael Hofstein
President&CEO, MaRS Innovation
 
Song Haeryong
Professor, Korea Univ. Guro Hospital
 
Hyun Gu Woo
Associate Professor, Ajou Univ. Hospital
 
Hayoon
Professor, Yonsei Severance Hospital
 
Seung Hee Han
Ph.D, Sunnybrook Health Science Center
 
Kim BJ
Research professor, CHA Univ. Bundang Medical Center
 
T10. Seminar on Current Medical Devices Market Status and Regulatory System in the Emerging Market (MedTech Fair 2017)
 
Ahmad Shariff Hambali
Principal Assistant Director, Medical Device Authority Malaysia
 
Shin, SungHo
Team Manager, KMDICA Indonesia Center
 
LI YONGFENG
Principal Manager, Diagnostics Development Hub, A*STAR
 
Mariana Bellido
Mexico UNIVERIX
 
Lic. Norma Aranda
Mexico UNIVERIX
 
 
T11. Global Medical Device Open Innovation Forum (MedTech Fair 2017)
 
Huiseok Chae
Researcher, Medical Device Industry Support Team, Korea Health Industry Development Institute
 
Crispina Tay
Regional Technologist, Asia Pacific Tech Scout, Global R&D, Boston Scientific
 
Mandar Gori
Senior Manager, Industry Development and Regional Partnership, Singapore-Stanford Biodesign, A*STAR
 
Joy Kim
Head of R&D Division, R&D Division, Genewel Co., Ltd.
 
Mickey Woosup Gwak
CEO, Smiths Medical Korea
 
Eul-Joon Park
CEO, Handok Kalosmedical
 
T12. The 6th GPKOL International Symposium 2017 (PICE KOREA 2017)
 
Mahmoud Alqawasmeh
 
 
Xavier Luria
Chair and Senior Consultant, Drug Development and Regulation(DDR)
 
Shayesteh Fürst-Ladani
CEO and founder, SFL Regulatory Affairs & Scientific Communication Ltd.
 
Ravil Niyazov
Head, Clinical Development
 
Lim Hyun Ja
 
 
Heemin Rhee
President, Health Research International
 
Eunjoo Pacifici
Associate Director, University of Southern California
 
Kwan R. Lee
Sr. Scientific Director, Johnson & Johnson
 
Liu lu
Head of Drug Research Institute, Drug Research Institute, Zhen Bao Dao Group
 
Abdullah Al Mesned
Chairman, Mesned Pharma Consult Center
 
Eman Ali Alawamleh
Registration Pharmacist, JFDA
 
Fouad Benghalem
CEO, Middle East & Africa Region, Emcure Pharmaceuticals
 
T13. 2017 Korea Pharmaceutical Industry Conference & Exhibition (PICE KOREA 2017)
 
Roberto Samayoa
Unit Chief, PAHO
 
Julio Cesar Valdes Diaz
Executive Secretary, SICA
 
Abdullah Al Zomai
CEO, Charisma Company
 
P. M. Murali
President, ABLE
 
Liya, Nie
VP, Northland